Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study

References

• BrometEAndradeLHHwangICross-national epidemiology of DSM-IV major depressive episodeBMC Med201199021791035
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Cooperation and DevelopmentECD Health Statistics 2013 Available from: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STATAccessed December 10, 2014
   Google Scholar
• MurrayCJVosTLozanoRDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592197222323245608
   PubMed Web of Science ®Google Scholar
• Institute for Health Metrics and EvaluationGlobal Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010)Seattle, WA, USAInstitute for Health Metrics and Evaluation2013
   Google Scholar
• NierenbergAAHusainMMTrivediMHResidual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D reportPsychol Med2010401415019460188
   PubMed Web of Science ®Google Scholar
• JuddLLPaulusMJSchettlerPJDoes incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?Am J Psychiatry200015791501150410964869
   PubMed Web of Science ®Google Scholar
• PaykelESRamanaRCooperZHayhurstHKerrJBarockaAResidual symptoms after partial remission: an important outcome in depressionPsychol Med1995256117111808637947
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry20061631284016390886
   PubMed Web of Science ®Google Scholar
• KimJMKimSWStewartRPredictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND studyHum Psychopharmacol2011261415021344501
   PubMed Web of Science ®Google Scholar
• LeuchterAFHusainMMCookIAPainful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) reportPsychol Med201040223925119493369
   PubMed Web of Science ®Google Scholar
• SilversteinBPatelPPoor response to antidepressant medication of patients with depression accompanied by somatic symptomatology in the STAR*D StudyPsychiatry Res20111871–212112421216475
   PubMed Web of Science ®Google Scholar
• DavisLLWisniewskiSRHowlandRHDoes comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomesDrug Alcohol Depend20101072–316117019945804
   PubMed Web of Science ®Google Scholar
• FavaMRushAJAlpertJEDifference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D reportAm J Psychiatry2008165334235118172020
   PubMed Web of Science ®Google Scholar
• StewartJWMcGrathPJFavaMDo atypical features affect outcome in depressed outpatients treated with citalopram?Int J Neuropsychopharmacol2010131153019341509
   PubMed Web of Science ®Google Scholar
• VanHLSchoeversRADekkerJPredicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic reviewHarv Rev Psychiatry200816422523418661365
   PubMed Web of Science ®Google Scholar
• DuenasHBrnabicAJLeeATreatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational periodInt J Psychiatry Clin Pract201115424225422121997
   PubMed Web of Science ®Google Scholar
• DuenasHLeeABrnabicAJFrequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational studyInt J Psychiatry Clin Pract2011152809022121855
   PubMed Web of Science ®Google Scholar
• World Health OrganizationThe ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic GuidelinesGeneva, SwitzerlandWorld Health Organization1992 Available from: http://www.who.int/classifications/icd/en/bluebook.pdfAccessed December 10, 2014
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders (Fourth Edition Text Revision)Washington, DC, USAAmerican Psychiatric Publishing2000
   Google Scholar
• GuyWECDEU Assessment Manual for Psychopharmacology (Revised)Bethesda, MD, USAUS Department of Health, Education and Welfare1976
   Google Scholar
• McGahueyCAGelenbergAJLaukesCAThe Arizona Sexual Experience Scale (ASEX): reliability and validityJ Sex Marital Ther2000261254010693114
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHIbrahimHMThe 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiol Psychiatry200354557358312946886
   PubMed Web of Science ®Google Scholar
• CirauloDAEvansJAQiuWQShaderRISalzmanCPharmacotherapy of depressionCirauloDAShaderRIClinical Pharmacology and Therapeutics of Antidepressants2nd edNew York, NY, USAHumana Press2011
   Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• KroenkeKSpitzerRLWilliamsJBPhysical symptoms in primary care. Predictors of psychiatric disorders and functional impairmentArch Fam Med1994397747797987511
   PubMedGoogle Scholar
• ThaseMEPritchettYLOssannaMJSwindleRWXuJDetkeMJEfficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorderJ Clin Psychopharmacol200727667267618004135
   PubMed Web of Science ®Google Scholar
• ThaseMENierenbergAAVrijlandPvan OersHJJSchutteA-JSimmonsJHRemission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depressionInt Clin Psychopharmacol201025418919820531012
   PubMed Web of Science ®Google Scholar
• ShrivastavaAJohnstonMBureauYStigma of Mental Illness-2: non-compliance and interventionMens Sana Monogr2012101859722654384
   PubMedGoogle Scholar
• HamdanAMental health needs of Arab womenHealth Care Women Int200930759561319492205
   PubMed Web of Science ®Google Scholar
• KornsteinSGSchatzbergAFThaseMEGender differences in treatment response to sertraline versus imipramine in chronic depressionAm J Psychiatry200015791445145210964861
   PubMed Web of Science ®Google Scholar
• KrellHVLeuchterAFCookIAAbramsMEvaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back painPsychosomatics200546537938416145181
   PubMed Web of Science ®Google Scholar
• SindrupSHOttoMFinnerupNBJensenTSAntidepressants in the treatment of neuropathic painBasic Clin Pharmacol Toxicol200596639940915910402
   PubMed Web of Science ®Google Scholar
• AtkinsonJHSlaterMACapparelliEVEfficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trialJ Clin Psychopharmacol200727213514217414235
   PubMed Web of Science ®Google Scholar
• JannMWSladeJHAntidepressant agents for the treatment of chronic pain and depressionPharmacotherapy200727111571158717963465
   PubMed Web of Science ®Google Scholar
• FavaMMallinckrodtCHDetkeMJWatkinJGWohlreichMMThe effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?J Clin Psychiatry200465452153015119915
   PubMed Web of Science ®Google Scholar
• GrecoTEckertGKroenkeKThe outcome of physical symptoms with treatment of depressionJ Gen Intern Med200419881381815242465
   PubMed Web of Science ®Google Scholar
• PerahiaDGSQuailDDesaiahDMontejoALSchatzbergAFSwitching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depressionJ Psychiatr Res200943551251818707693
   PubMed Web of Science ®Google Scholar
• AngstJSexual problems in healthy and depressed personsInt Clin Psychopharmacol199813Suppl 6S1S49728667
   PubMed Web of Science ®Google Scholar
• BonierbaleMLanconCTignolJThe ELIXIR study: evaluation of sexual dysfunction in 4,557 depressed patients in FranceCurr Med Res Opin200319211412412740155
   PubMed Web of Science ®Google Scholar